Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine Italiano

Showing results (41-50 of 418) with videos related to

Pageof 42
Sort By:
Haematologica|September 13, 2005
Adapted CHOP plus rituximab in non-Hodgkin's lymphoma in patients over 80 years oldAntoine Italiano, Fabrice Jardin, Frederic Peyrade, et al.
Cancers|August 19, 2020
MDM2 Antagonists Induce a Paradoxical Activation of Erk1/2 through a P53-Dependent Mechanism in Dedifferentiated Liposarcomas: Implications for Combinatorial StrategiesShomereeta Roy, Audrey Laroche-Clary, Stephanie Verbeke, et al.
Journal of Imaging Informatics in Medicine|July 17, 2024
Metastatic Lung Adenocarcinomas: Development and Evaluation of Radiomic-Based Methods to Measure Baseline Intra-Patient Inter-Tumor Lesion HeterogeneityMathilde Lafon, Sophie Cousin, Mélissa Alamé, et al.
Cancers|October 13, 2021
High Prevalence of 5T4/Trophoblast Glycoprotein in Soft Tissue SarcomasPatrick Groothuis, Nicola Penel, Antoine Italiano, et al.
European Journal of Radiology|September 27, 2020
Systematic review of sarcomas radiomics studies: Bridging the gap between concepts and clinical applications?Amandine Crombé, David Fadli, Antoine Italiano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2025
Synergistic Effects of ATR Inhibition and Lurbinectedin in Soft-Tissue Sarcomas: The Predictive Role of SLFN11 ExpressionAudrey Laroche-Clary, Vanessa Chaire, Veronica Valverde, et al.
Cancer Medicine|April 16, 2018
Prospective assessment of the predictive value of the BRCA1 gene status in sarcoma patients treated with trabectedin: an updated analysis of the EORTC 62091 trialAntoine Italiano, Nathan Touati, Saskia Litière, et al.
Future Oncology (London, England)|December 5, 2014
Long clinical benefit achieved in two patients with malignant paraganglioma treated by metronomic cyclophosphamidePauline Gillon, Yann Godbert, Charles Dupin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2011
Quality of randomized controlled trials reporting in the treatment of sarcomasMaud Toulmonde, Carine Bellera, Simone Mathoulin-Pelissier, et al.
Anti-Cancer Drugs|February 9, 2011
Temsirolimus in advanced leiomyosarcomas: patterns of response and correlation with the activation of the mammalian target of rapamycin pathwayAntoine Italiano, Michèle Kind, Eberhard Stoeckle, et al.
Pageof 42

Showing results (41-50 of 418) with videos related to

Sort By:
Pageof 42
Haematologica|September 13, 2005
Adapted CHOP plus rituximab in non-Hodgkin's lymphoma in patients over 80 years oldAntoine Italiano, Fabrice Jardin, Frederic Peyrade, et al.
Cancers|August 19, 2020
MDM2 Antagonists Induce a Paradoxical Activation of Erk1/2 through a P53-Dependent Mechanism in Dedifferentiated Liposarcomas: Implications for Combinatorial StrategiesShomereeta Roy, Audrey Laroche-Clary, Stephanie Verbeke, et al.
Journal of Imaging Informatics in Medicine|July 17, 2024
Metastatic Lung Adenocarcinomas: Development and Evaluation of Radiomic-Based Methods to Measure Baseline Intra-Patient Inter-Tumor Lesion HeterogeneityMathilde Lafon, Sophie Cousin, Mélissa Alamé, et al.
Cancers|October 13, 2021
High Prevalence of 5T4/Trophoblast Glycoprotein in Soft Tissue SarcomasPatrick Groothuis, Nicola Penel, Antoine Italiano, et al.
European Journal of Radiology|September 27, 2020
Systematic review of sarcomas radiomics studies: Bridging the gap between concepts and clinical applications?Amandine Crombé, David Fadli, Antoine Italiano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2025
Synergistic Effects of ATR Inhibition and Lurbinectedin in Soft-Tissue Sarcomas: The Predictive Role of SLFN11 ExpressionAudrey Laroche-Clary, Vanessa Chaire, Veronica Valverde, et al.
Cancer Medicine|April 16, 2018
Prospective assessment of the predictive value of the BRCA1 gene status in sarcoma patients treated with trabectedin: an updated analysis of the EORTC 62091 trialAntoine Italiano, Nathan Touati, Saskia Litière, et al.
Future Oncology (London, England)|December 5, 2014
Long clinical benefit achieved in two patients with malignant paraganglioma treated by metronomic cyclophosphamidePauline Gillon, Yann Godbert, Charles Dupin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2011
Quality of randomized controlled trials reporting in the treatment of sarcomasMaud Toulmonde, Carine Bellera, Simone Mathoulin-Pelissier, et al.
Anti-Cancer Drugs|February 9, 2011
Temsirolimus in advanced leiomyosarcomas: patterns of response and correlation with the activation of the mammalian target of rapamycin pathwayAntoine Italiano, Michèle Kind, Eberhard Stoeckle, et al.
Pageof 42